Navigation Links
Balzan Foundation announces 2007 winners
Date:9/5/2007

ture in the Middle Ages, a decisive chapter in the development of modern European literature; for his new interpretation of the relation between medieval and modern literature; for his seminal initiatives that have brought the literature of the Middle Ages back into the cultural tradition of France and Europe".

Nicole Le Douarin (Honorary Permanent Secretary of the Acad mie des Sciences and Honorary Professor at the Collge de France) justified the assignment of the Prize for Innate Immunity jointly to Bruce Beutler and Jules Hoffmann as follows: "for their discovery of the genetic mechanisms responsible for innate immunity. They have worked in close cooperation to develop a new vision of the molecular defence strategy deployed by animals across a wide evolutionary spectrum against infectious agents. Their work has led to very promising medical applications".

Nicola Cabibbo (Professor of Physics at the University La Sapienza in Rome, Fellow of the Accademia Nazionale dei Lincei in Rome and President of the Pontifical Academy of Sciences) justified the assignment of the Prize for Nanoscience to Sumio Iijima as follows: "for his discovery of carbon nanotubes and in particular the discovery of single walled carbon nanotubes and the study of their properties".

The President of the Balzan Foundation "Prize", Ambassador Bruno Bottai motivated the assignment of the Balzan Prize for Humanity, Peace and Brotherhood among Peoples to Karlheinz Bhm as follows: "for his life's work serving humanity and peace, for his extraordinary personal commitment, for the successful, outstanding network of activities he has created to support concrete affirmative action in Ethiopia, a country with one of the most ancient cultures in the world, but one of the poorest".

The President of the General Prize Committee, Sergio Romano, added that the awarded subjects, which vary each year, make it possible to encourage specific fields of study which are new or
'/>"/>

Contact: Susannah Gold
info@goldcommunications.net
212-222-7595
Gold Communications
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. W.M. Keck Foundation funds study of friendly microbes
2. Digging in the dirt for lifes biochemical foundations
3. Protein folding: Building a strong foundation
4. Wiley announces publication of Databasing the Brain
5. Nonlinear Dynamics announces more details of its global partnership with PerkinElmer
6. FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
7. Ariadne Genomics Announces the Release of PathwayStudio?Central, Client-Server Software for Biological Pathway Analysis
8. Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease
9. Eisai announces Phase II data on E7389, a potential new therapy for the treatment of breast cancer
10. GlycoFi announces the first production of antibodies with human glycosylation in yeast
11. NHGRI announces new sequencing targets
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4
Other Biology Technology:Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results 2Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results 3Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results 4Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results 5Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results 6BMP Sunstone Reports Third Quarter 2008 Financial Results 2BMP Sunstone Reports Third Quarter 2008 Financial Results 3BMP Sunstone Reports Third Quarter 2008 Financial Results 4BMP Sunstone Reports Third Quarter 2008 Financial Results 5BMP Sunstone Reports Third Quarter 2008 Financial Results 6BMP Sunstone Reports Third Quarter 2008 Financial Results 7BMP Sunstone Reports Third Quarter 2008 Financial Results 8BMP Sunstone Reports Third Quarter 2008 Financial Results 9BMP Sunstone Reports Third Quarter 2008 Financial Results 10BMP Sunstone Reports Third Quarter 2008 Financial Results 11BMP Sunstone Reports Third Quarter 2008 Financial Results 12BMP Sunstone Reports Third Quarter 2008 Financial Results 13BMP Sunstone Reports Third Quarter 2008 Financial Results 14Endocare Reports Financial Results for Third Quarter 2008 2Endocare Reports Financial Results for Third Quarter 2008 3Endocare Reports Financial Results for Third Quarter 2008 4Endocare Reports Financial Results for Third Quarter 2008 5Endocare Reports Financial Results for Third Quarter 2008 6Endocare Reports Financial Results for Third Quarter 2008 7Endocare Reports Financial Results for Third Quarter 2008 8Endocare Reports Financial Results for Third Quarter 2008 9Endocare Reports Financial Results for Third Quarter 2008 10Endocare Reports Financial Results for Third Quarter 2008 11